CompletedNCT00034905
Quetiapine or risperidone for schizophrenia
About this title
Read the official source — NCT00034905Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Birmingham and 63 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJuly 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00034905
- Official title
Show the full official title
A Comparison of Seroquel vs. Risperidone in Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Phoenix · Anaheim
61 more locations
- Cerritos
- Chula Vista
- Glendale
- Hawthorne
- Long Beach
- San Diego
- Santa Ana
- Torrance
- Farmington
- New Haven
- Washington D.C.
- Miami
- Miami Beach
- North Miami
- Winter Park
- Atlanta
- Hoffman Estates
- Prairie Village
- Wichita
- New Orleans
- Shreveport
- Baltimore
- Boston
- Worcester
- Ann Arbor
- New Baltimore
- Kansas City
- St Louis
- Reno
- Clementon
- Lyons
- Summit
- Albuquerque
- Holliswood
- Montrose
- New York
- Oceanside
- The Bronx
- White Plains
- Butner
- Beachwood
- Chagrin Falls
- Cincinnati
- Columbus
- Oklahoma City
- Media
- Pittsburgh
- Memphis
- Nashville
- Austin
- Houston
- Terrell
- Waco
- Salt Lake City
- Falls Church
- Richmond
- Virginia Beach
- Kirkland
- Tacoma
- Vancouver
- West Allis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Did this study involve medication?
Yes. The study involved medication, including quetiapine fumarate vs risperidone.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
